Giuseppe Barilaro | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Efficacy of long‐acting cabotegravir plus rilpivirine in viraemic people living with HIV: A systematic review and meta‐analysis	HIV MEDICINE	2025
Predictors of Mortality in Antiphospholipid Antibody–Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository	ARTHRITIS CARE & RESEARCH	2025
Targeting sphingosine-1-phosphate receptor modulator in SLE: a promising new therapeutic option	THE LANCET. RHEUMATOLOGY	2025
Is it time for treat-to-target in antiphospholipid syndrome?	AUTOIMMUNITY REVIEWS	2025
Antiphospholipid Syndrome	Autoimmune Disease Diagnosis: Systemic and Organ-specific Diseases, Second Edition	2025
Systemic Lupus Erythematosus	Autoimmune Disease Diagnosis: Systemic and Organ-specific Diseases, Second Edition	2025
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus	AUTOIMMUNITY REVIEWS	2024
Anti-NET antibodies in antiphospholipid antibody-positive patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository	ARTHRITIS & RHEUMATOLOGY	2023
Twelve-month clinical, functional, and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia	JOURNAL OF MEDICAL VIROLOGY	2023
Mortality and causes of death in systemic lupus erythematosus revisited	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2023
Fluctuation of Anti-Domain 1 and Anti-β2 -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies	ARTHRITIS & RHEUMATOLOGY	2023
Predictive value of the Adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: A longitudinal study	RHEUMATOLOGY	2022
Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center	ARTHRITIS RESEARCH & THERAPY	2022
FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities	CLINICAL DRUG INVESTIGATION	2022
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	AUTOIMMUNITY REVIEWS	2022
Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome	JOURNAL OF CLINICAL MEDICINE	2022
The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study	RHEUMATOLOGY	2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")	LUPUS	2022
Impact of the COVID-19 pandemic on multidrug-resistant hospital-acquired bacterial infections	JOURNAL OF HOSPITAL INFECTION	2022
The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study	ARTHRITIS RESEARCH & THERAPY	2022